What is the global market size of Single Use Bioreactors Market?

Global single use bioreactors market was valued at USD 3.42 billion in 2021, and it is expected to attain a value of USD 10.8 billion by 2028 with a CAGR of 21.1% over the prediction period (2022-2028). Read More

What is the key driver of Global Single Use Bioreactors Market?

Due to the growing geriatric population's increased susceptibility to a wide range of diseases, there is a rising demand for biopharmaceuticals on a global scale. Global corporations are concentrating on biopharmaceutical R&D and manufacturing for product development and increased production in response to this demand. Workflows for manufacturing biopharmaceuticals must include single-use technologies. Particularly in clinical testing, R&D, and small- and mid-scale biopharmaceutical manufacturing, they represent a significant portion of the industry. Single-use systems have become more popular in biopharmaceutical R&D due to their advantages over traditional manufacturing methods. As a result, it is believed that rising R&D spending is a sign that the market is expanding. Read More

What is the key market trend for Global Single Use Bioreactors Market?

A disposable bag is used in a single-use bioreactor (SUB), also referred to as a disposable bioreactor, in place of a culture vessel made of stainless steel or glass. It requires fewer utilities, such as steam and water, is flexible, simple to install, and easy to use. In addition, it lowers labor costs, lessens the chance of cross-contamination, and does away with cleaning procedures and validation problems. It consequently has a wide range of uses in contract research organizations (CROs) and contract manufacturing organizations (CMOs) all over the world. Read More

Single Use Bioreactors Market Size, Share, Growth Analysis, By Product(Single-Use Bioreactors Systems, Single-Use Media Bags, Single-Use Filtration Assemblies, Others), By Type(Stirred-Tank Subs, Wave-Induced Subs, Bubble-Column Subs, Other Subs), By Molecule Type(Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells), By End-User(Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes), By Region - Industry Forecast 2024-2031

Q: Which region accounted for the largest share in Global Single Use Bioreactors Market?

The largest revenue share, at over 30%, was earned by North America. This is explained by the presence of significant operating players and the region's well-established biopharmaceutical industry. Additionally, the region's increased manufacturing capacity has added to the market expansion. For instance, Thermo Fisher Scientific announced in September 2021 that it intended to build a new manufacturing facility specifically for single-use bioprocessing products. The addition of the Nashville location increased its network of SUT manufacturing facilities on a global scale. The changing environment for manufacturing and bioprocessing is a key driver of market expansion in the United States. Read More

Report ID: SQMIG35H2227 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 121 | Figures: 77

Single Use Bioreactors Market News

In March 2021, HyPerforma DynaDrive single-use bioreactors with capacities of 3,000 L and 5,000 L were introduced by Thermo Fisher Scientific. The goal of this launch was to satisfy the significant demand for industrial-scale single-use bioprocessing.
In January 2021, Sartorius worked with RoosterBio, Inc to improve the manufacturing capabilities for gene and cell therapies. The partnership aims to increase the output of regenerative medicine. One of the major players on the market for single-use bioreactors is Sartorius.

Single Use Bioreactors Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Single Use Bioreactors Market size was valued at USD 2.81 billion in 2019 and is poised to grow from USD 3.30 billion in 2023 to USD 12.06 billion by 2031, growing at a CAGR of 17.19% in the forecast period (2024-2031).

The market is rapidly developing, and in the upcoming years, it is anticipated that market competition will rise. The increasing use of disposable bioreactors has led to an increase in new market entrants, which has in turn heightened competition. To maintain their market presence, the major market players are engaging in a number of strategic initiatives. One of the key strategies used by the major market players is the introduction of new products. Other key strategies include mergers and acquisitions and capacity expansion. 'Thermo Fisher Scientific Inc.', 'Sartorius AG', 'Merck KGaA', 'Danaher Corporation', 'Applikon Biotechnology BV', 'Eppendorf AG', 'Pall Corporation', 'GE Healthcare', 'Celltainer Biotech BV', 'Distek, Inc.', 'PBS Biotech Inc.', 'Cellexus Ltd.', 'Parker Hannifin Corporation', 'Bioengineering AG', 'Solida Biotech GmbH', 'CerCell ApS', 'Avantor, Inc.', 'ABL Biotechnologies Ltd.', 'Finesse Solutions, Inc.', 'Kuhner AG'

Due to the growing geriatric population's increased susceptibility to a wide range of diseases, there is a rising demand for biopharmaceuticals on a global scale. Global corporations are concentrating on biopharmaceutical R&D and manufacturing for product development and increased production in response to this demand.

Growing adoption in the bioprocessing sector: The high rate of adoption of SUBs in the bioprocessing sector is likely to augment the market share in the coming years. Owing to the benefits such as flexibility, scalability, and lower time costs offered through SUBs is likely to be witnessed.

North America maintained a huge dominance and is expected to continue a leading position owing to the presence of significant operating players and the region's well-established biopharmaceutical industry. Additionally, the region's increased manufacturing capacity has added to the market expansion. For instance, Thermo Fisher Scientific announced in September 2021 that it intended to build a new manufacturing facility specifically for single-use bioprocessing products. The addition of the Nashville location increased its network of SUT manufacturing facilities on a global scale. The changing environment for manufacturing and bioprocessing is a key driver of market expansion in the United States.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Single Use Bioreactors Market News

Single Use Bioreactors Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Single Use Bioreactors Market?

Who are the key vendors in the Single Use Bioreactors Market?

What is the key driver of Single Use Bioreactors Market?

What is the key market trend for Single Use Bioreactors Market?

Which region accounted for the largest share in Single Use Bioreactors Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300